Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility
- PMID: 17624345
- PMCID: PMC2366795
- DOI: 10.1016/j.fertnstert.2007.03.089
Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility
Abstract
Objective: To examine whether use of multivitamins and intake of specific nutrients in multivitamins is associated with ovulatory infertility.
Design: A prospective cohort study.
Setting: The Nurses' Health Study II.
Patient(s): Eighteen thousand five hundred fifty-five married, premenopausal women without a history of infertility who attempted a pregnancy or became pregnant between 1991 and 1999.
Intervention(s): None, observational study.
Main outcome measure(s): Incident reports of infertility caused by anovulation.
Result(s): During 8 years of follow-up, 438 women reported infertility caused by ovulatory disorder. There was an inverse association between frequency of multivitamin use and ovulatory infertility. The multivariate-adjusted relative risk (95% confidence interval) of ovulatory infertility was 0.88 (0.60, 1.28) for women consuming two tablets per week or less, 0.69 (0.51, 0.95) for women consuming three to five tablets per week, and 0.59 (0.46, 0.75) for women consuming six or more tablets per week, when compared with women who did not use these supplements (P, trend <.001). Folic acid appeared to explain part of the association between multivitamin supplement use and risk of ovulatory infertility.
Conclusion(s): Regular use of multivitamin supplements may decrease the risk of ovulatory infertility.
Figures

References
-
- Evers JLH. Female subfertility. Lancet. 2002;360:151–159. - PubMed
-
- Pinelli A, Di Cesare M. Human fertility: sociodemographic aspects. Contraception. 2005;72:303–307. - PubMed
-
- Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilization. N Engl J Med. 1994;331:239–243. - PubMed
-
- Katz P, Nachtigall R, Showstack J. The economic impact of the assisted reproductive technologies. Nature Med. 2002;8:S29–S32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL03804/HL/NHLBI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- CA55075/CA/NCI NIH HHS/United States
- CA67262/CA/NCI NIH HHS/United States
- DK52866/DK/NIDDK NIH HHS/United States
- T32 DK007703/DK/NIDDK NIH HHS/United States
- R01 HL064108/HL/NHLBI NIH HHS/United States
- CA50385/CA/NCI NIH HHS/United States
- R01 CA067883/CA/NCI NIH HHS/United States
- AG/CA14742/AG/NIA NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- HL64108/HL/NHLBI NIH HHS/United States
- T32 DK-007703/DK/NIDDK NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- R01 CA065725/CA/NCI NIH HHS/United States
- CA67883/CA/NCI NIH HHS/United States
- CA65725/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical